Up a level |
Jamali, A. and Mahdavi, M. and Hassan, Z.M. and Sabahi, F. and Farsani, M.J. and Bamdad, T. and Soleimanjahi, H. and Motazakker, M. and Shahabi, S. (2009) A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine. International Immunology, 21 (3). pp. 217-225.